Brain FET PET tumor‐to‐white mater ratio to differentiate recurrence from post‐treatment changes in high‐grade gliomas AD Puranik, V Rangarajan, ID Dev, Y Jain, NC Purandare, A Sahu, ... Journal of Neuroimaging 31 (6), 1211-1218, 2021 | 18 | 2021 |
Utility of FET-PET in detecting high-grade gliomas presenting with equivocal MR imaging features AD Puranik, M Boon, N Purandare, V Rangarajan, T Gupta, A Moiyadi, ... World Journal of Nuclear Medicine 18 (3), 266, 2019 | 9 | 2019 |
Congenital Melanocytic Nevi Syndrome With Leptomeningeal Melanoma. A Mohite, A Agrawal, N Purandare, S Shah, A Puranik, S Choudhury, ... Clinical Nuclear Medicine, 2022 | 3 | 2022 |
Prospective study to assess the role of FDG PET/CT in detecting systemic metastatic spread in rectal cancers with lateral pelvic lymph nodes A Agrawal, M Kazi, J Gori, I Dev, V Rangarajan, A Veer, P Patil, ... European Journal of Surgical Oncology, 2021 | 3 | 2021 |
Prognostic significance of 18F-FDG PET/CT parameters in IDH-1 wild-type GBM and correlation with molecular markers ID Dev, AD Puranik, NC Purandare, T Gupta, E Sridhar, P Shetty, ... Nuclear Medicine Communications 42 (11), 1233-1238, 2021 | 2 | 2021 |
Unusual Variant of Breast Cancer Presenting With Pituitary Symptoms Detected on 68Ga-DOTATATE PET/CT. ID Dev, AD Puranik, V Rangarajan, NC Purandare, A Agrawal, S Shah, ... Clinical Nuclear Medicine, 2021 | 1 | 2021 |
Performance of dedicated 18 F FDG PETCT and derived metabolic parameters in brain space occupying lesions (SOLs) suspicious for primary CNS lymphoma Y JAIN, A PURANIK, V RANGARAJAN, I DEV, N PURANDARE, ... Journal of Nuclear Medicine 63 (supplement 2), 2935-2935, 2022 | | 2022 |
Amino acid imaging with FET PET IN DIFFERENTIATING RECURRENCE FROM POST TREATMENT CHANGES: Impact of IDH1 mutation status. I DEV, A PURANIK, N PURANDARE, E SRIDHAR, A SAHAY Journal of Nuclear Medicine 63 (supplement 2), 2929-2929, 2022 | | 2022 |
Amino-acid PET/CT with 18-F FET PET/CT for differentiating recurrence from radiation-induced changes in WHO Grade III and IV Gliomas. I DEV, A PURANIK, V RANGARAJAN, N PURANDARE, A AGRAWAL, ... Journal of Nuclear Medicine 63 (supplement 2), 2920-2920, 2022 | | 2022 |
Rare presentation of radiation-induced sarcoma detected on F-18 FDG positron emission tomography/computed tomography in a treated case of giant cell tumor ID Dev, AD Puranik, V Rangarajan, NC Purandare, A Agrawal, S Shah, ... Indian Journal of Nuclear Medicine 36 (4), 429, 2021 | | 2021 |
All that glitters on PSMA is not a lesion: An unusual artifact on PSMA PET/CT ID Dev, V Rangarajan, NC Purandare, A Agrawal, S Shah, AD Puranik Indian Journal of Nuclear Medicine: IJNM: The Official Journal of the …, 2021 | | 2021 |
Radiation-Induced Meningioma in a Case of Medulloblastoma Treated 11 Years Ago-Detected on 68Ga-DOTANOC PET/CT. ID Dev, AD Puranik, V Rangarajan, T Gupta, NC Purandare, A Agrawal, ... Clinical Nuclear Medicine, 2021 | | 2021 |
Prior Surgical Resection and Ga-68-DOTANOC PET/CT Imaging-Based Parameters: Do These Impact Outcomes in Grade II Gastroentero-Pancreatic Neuroendocrine Tumors (GEP-NETs) A Puranik, A Agrawal, V Rangarajan, S Shrikhande, I Dev, A Ramaswamy, ... NEUROENDOCRINOLOGY 110, 172-172, 2020 | | 2020 |
Role of baseline 18F FDG positron emission tomography computed tomography metabolic parameters in prediction of disease free survival in patients with … A Mohite, V Rangarajan, N Purandare, A Agrawal, S Shah, A Puranik, ... Indian Journal of Nuclear Medicine 34 (5, suppl. 1), 29, 2019 | | 2019 |
Clinical impact of 18F FET positron emission tomography computed tomography in differentiating suspected recurrence from posttreatment changes in IDH1 mutant and wild type high … ID Dev, AD Puranik, N Purandare, A Agrawal, S Shah, V Rangarajan Indian Journal of Nuclear Medicine 34 (5, suppl. 1), 28, 2019 | | 2019 |
Diagnostic utility of 18F FDG positron emission tomography/computed tomography and derived metabolic parameters in detection of brain sols suspicious for … Y Jain, I Dev, A Puranik, NC Purandare, A Agrawal, S Shah, ... Indian Journal of Nuclear Medicine 34 (5, suppl. 1), 28, 2019 | | 2019 |